Get informed when a big investor buys or sells
+ FollowOvervalued by 124.3% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $163.54 Million |
|---|---|
| Enterprise Value | $165.62 Million |
| Earnings per Share | $0.22 |
| Beta | 2.09 |
| Outstanding Shares | 79,149,000 |
| P/E Ratio | 16.31 |
|---|---|
| PEG | -12.98 |
| Price to Sales | - |
| Price to Book Ratio | 2.04 |
| Enterprise Value to Revenue | 2.91 |
| Enterprise Value to EBIT | 32.57 |
| Enterprise Value to Net Income | 16 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.03 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
ChromaDex Corp. is a science-based integrated nutraceutical company devoted to improving the way people age. ChromaDex scientists partner with leading universities and research institutions worldwide to discover, develop and create solut...